For help on how to get the results you want, see our search tips.
125 results
-
List item
Referral: Okrido
prednisolone sodium phosphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 05/09/2013, Last updated: 03/01/2014 -
List item
Referral: Didanosine
didanosine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/09/2013, EC decision date: 20/11/2013, Last updated: 10/12/2013 -
List item
Referral: Methylphenidate Sandoz
methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013 -
List item
Referral: Methylphenidate Hexal
methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013 -
List item
Referral: Ciclosporin IDL
ciclosporin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 22/07/2010, Last updated: 20/11/2013 -
List item
Referral: Avalox
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013 -
List item
Referral: Furosemide Vitabalans
furosemide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/02/2013, EC decision date: 14/05/2013, Last updated: 30/07/2013 -
List item
Referral: Simvastatin Vale
simvastatin, associated names: Simvastatin Vale pharmaceuticals, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/03/2013, EC decision date: 27/05/2013, Last updated: 22/07/2013 -
List item
Referral: Loraxin
loratadine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2012, EC decision date: 20/12/2012, Last updated: 28/02/2013 -
List item
Referral: Mometasone Furoate Sandoz
mometasone furoate, associated names: Mometasone Sandoz, Mometasone Sandoz 50, Mometasone Furoato Sandoz 50, Mommox, Nasometi, Fumomo 50, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 08/10/2012, Last updated: 24/01/2013 -
List item
Referral: Mifepristone Linepharma
mifepristone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 11/09/2012, Last updated: 03/01/2013 -
List item
Referral: Yvidually
ethinylestradiol, drospirenone, associated names: Flexyess, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/09/2012, Last updated: 03/01/2013 -
List item
Referral: Glimepirida Parke-Davis
glimepiride, associated names: Glimepiride Pfizer, Glimepirid Pfizer, Glimepiride tablets 2 mg, Glimepiride tablets 3 mg, Glimepiride tablets 4 mg, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 19/11/2012, Last updated: 06/12/2012 -
List item
Referral: Iffeza
fluticasone propionate, formoterol fumarate, associated names: Flutiform, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012 -
List item
Referral: Flutiform
fluticasone propionate, formoterol fumarate, associated names: Iffeza, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012 -
List item
Referral: Docetaxel Teva Generics
docetaxel, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/02/2011, EC decision date: 07/07/2011, Last updated: 03/07/2012 -
List item
Referral: Galantamine Stada
galantamine, associated names: Galantamina, Galantamine Tiefenbacher, Galantamina Ciclum, Galatnax xl, Galastad, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 21/02/2011, Last updated: 08/06/2012 -
List item
Referral: Priligy
dapoxetine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 20/01/2012, Last updated: 28/03/2012 -
List item
Referral: Canazole
clotrimazole, associated names: Canesten, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 22/09/2011, Last updated: 09/02/2012 -
List item
Referral: Dexamethasone Alapis
dexamethasone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/07/2011, EC decision date: 24/10/2011, Last updated: 02/02/2012 -
List item
Referral: Levothyroxine Alapis
levothyroxine sodium, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2012, EC decision date: 14/01/2013, Last updated: 19/01/2012 -
List item
Referral: Prevora
chlorhexidine diacetate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 03/12/2010, Last updated: 20/09/2011 -
List item
Referral: Norsed Combi D
risedronate sodium, Calcium carbonate, colecalciferol, associated names: Actonel Combi D, Optinate Plus Ca&D, Opticalcio D3, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 05/10/2010, Last updated: 13/09/2011 -
List item
Referral: Fortipan Combi D
risedronate sodium, Calcium carbonate, colecalciferol, associated names: Actocalcio D3, Acrelcombi, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 05/10/2010, Last updated: 13/09/2011 -
List item
Referral: Clopidogrel Teva
clopidogrel, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/02/2010, EC decision date: 04/06/2010, Last updated: 08/09/2011